Document and Entity Information
Document and Entity Information | Sep. 08, 2023 |
Cover [Abstract] | |
Amendment Flag | true |
Entity Central Index Key | 0001512762 |
Document Type | 8-K/A |
Document Period End Date | Sep. 08, 2023 |
Entity Registrant Name | COHERUS BIOSCIENCES, INC. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-36721 |
Entity Tax Identification Number | 27-3615821 |
Entity Address, Address Line One | 333 Twin Dolphin Drive |
Entity Address, Address Line Two | Suite 600 |
Entity Address, City or Town | Redwood City |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94065 |
City Area Code | (650) |
Local Phone Number | 649-3530 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.0001 par value per share |
Trading Symbol | CHRS |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Amendment Description | On September 8, 2023, Coherus BioSciences, Inc. (the “Company”) filed a Current Report on Form 8-K (as amended on November 6, 2023, the “Original Form 8-K”) reporting that on September 8, 2023, pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) dated June 15, 2023 by and among the Company, Crimson Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub I”), Crimson Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (“Merger Sub II”), and Surface Oncology, Inc., a Delaware corporation (“Surface”), Merger Sub I merged with and into Surface (the “First Merger”), with Surface surviving such First Merger as a wholly owned subsidiary of the Company, and, as part of the same overall transaction, promptly after the First Merger, the surviving entity of the First Merger merged with and into Merger Sub II (the “Second Merger” and together with the First Merger, the “Mergers”), with Merger Sub II surviving the Second Merger. |